Macquarie Group
ORGO icon

Macquarie Group’s Organogenesis Holdings ORGO Stock Holding History

Macquarie Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62
Closed -$280 – 2529
2022
Q2 		$0 Hold
62
– – ﹤0.01% 2609
2022
Q1 		$0 Sell
62
-2,262,990
-100% -$17.5M ﹤0.01% 2636
2021
Q4 		$20.9M Buy
2,263,052
+1,023,794
+83% +$10.9M 0.02% 742
2021
Q3 		$17.6M Buy
+1,239,258
New +$19.2M 0.02% 797

Other funds holding ORGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Macquarie Group's ORGO Position: Q3 2022 in Review

Macquarie Group sold out of Organogenesis Holdings (ORGO) in Q3 2022, closing a stake of 62 shares — an estimated $280 sold.

Macquarie Group first reported a position in ORGO in Q3 2021 and held it in 4 quarters. The position peaked at $20.9M in Q4 2021. 154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

  • Macquarie Group reported no remaining Organogenesis Holdings position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 62 Organogenesis Holdings shares in Q3 2022, an estimated $280.
  • Macquarie Group first reported a position in Organogenesis Holdings in Q3 2021 and held it in 4 quarters.
  • Macquarie Group's Organogenesis Holdings position peaked at $20.9M in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.